View Item 

Show simple item record

Bergamottin contribution to the grapefruit juice–felodipine interaction and disposition in humans

dc.contributor.authorGoosen, Theunis C.en_US
dc.contributor.authorCillié, Doréen_US
dc.contributor.authorBailey, David G.en_US
dc.contributor.authorYu, Chongwooen_US
dc.contributor.authorHe, Kanen_US
dc.contributor.authorHollenberg, Paul F.en_US
dc.contributor.authorWoster, Patrick M.en_US
dc.contributor.authorCohen, Lucindaen_US
dc.contributor.authorWilliams, J. Andrewen_US
dc.contributor.authorRheeders, Malieen_US
dc.contributor.authorDijkstra, H. Paulen_US
dc.date.accessioned2015-01-07T15:23:22Z
dc.date.available2015-01-07T15:23:22Z
dc.date.issued2004-12en_US
dc.identifier.citationGoosen, Theunis C.; Cillié, Doré ; Bailey, David G.; Yu, Chongwoo; He, Kan; Hollenberg, Paul F.; Woster, Patrick M.; Cohen, Lucinda; Williams, J. Andrew; Rheeders, Malie; Dijkstra, H. Paul (2004). "Bergamottin contribution to the grapefruit juiceâ felodipine interaction and disposition in humans." Clinical Pharmacology & Therapeutics 76(6): 607-617.en_US
dc.identifier.issn0009-9236en_US
dc.identifier.issn1532-6535en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109856
dc.publisherWiley Periodicals, Inc.en_US
dc.titleBergamottin contribution to the grapefruit juice–felodipine interaction and disposition in humansen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109856/1/cptclpt2004537.pdf
dc.identifier.doi10.1016/j.clpt.2004.08.019en_US
dc.identifier.sourceClinical Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceSahi, J., Reyner, E. L., Bauman, J. N., Gueneva‐Boucheva, K., Burleigh, J. E. and Thomas, V. H. ( 2002 ). The effect of bergamottin on diazepam plasma levels and P450 enzymes in beagle dogs. Drug Metab Dispos. 30: 135 – 140.en_US
dc.identifier.citedreferenceOhta, T., Nagahashi, M., Hosoi, S. and Tsukamoto, S. ( 2002 ). Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor. Bioorg Med Chem. 10: 969 – 973.en_US
dc.identifier.citedreferenceSchmiedlin‐Ren, P., Edwards, D. J., Fitzsimmons, M. E., He, K., Lown, K. S. and Woster, P. M., et al. ( 1997 ). Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: Decreased enterocyte CYP3A4 concentration and mechanism‐based inactivation by furanocoumarins. Drug Metab Dispos. 25: 1228 – 1233.en_US
dc.identifier.citedreferenceGreenblatt, D. J., von Moltke, L. L., Harmatz, J. S., Chen, G., Weemhoff, J. L. and Jen, C., et al. ( 2003 ). Time course of recovery of cytochrome P450 3A function after single doses of grapefruit juice. Clin Pharmacol Ther. 74: 121 – 129.en_US
dc.identifier.citedreferenceEdwards, D. J., Bellevue, F. H. III and Woster, P. M. ( 1996 ). Identification of 6′,7′‐dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos. 24: 1287 – 1290.en_US
dc.identifier.citedreferenceGuo, L. Q., Taniguchi, M., Xiao, Y. Q., Baba, K., Ohta, T. and Yamazoe, Y. ( 2000 ). Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol. 82: 122 – 129.en_US
dc.identifier.citedreferenceBailey, D. G., Kreeft, J. H., Munoz, C., Freeman, D. J. and Bend, J. R. ( 1998 ). Grapefruit juice‐felodipine interaction: effect of naringin and 6′,7′‐dihydroxybergamottin in humans. Clin Pharmacol Ther. 64: 248 – 256.en_US
dc.identifier.citedreferenceKakar, S. M., Paine, M. F., Stewart, P. W. and Watkins, P. B. ( 2004 ). 6′7′‐Dihydroxybergamottin contributes to the grapefruit juice effect. Clin Pharmacol Ther. 75: 569 – 579.en_US
dc.identifier.citedreferenceWang, E. J., Casciano, C. N., Clement, R. P. and Johnson, W. W. ( 2001 ). Inhibition of P‐glycoprotein transport function by grapefruit juice psoralen. Pharm Res. 18: 432 – 438.en_US
dc.identifier.citedreferenceFukuda, K., Ohta, T., Oshima, Y., Ohashi, N., Yoshikawa, M. and Yamazoe, Y. ( 1997 ). Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics. 7: 391 – 396.en_US
dc.identifier.citedreferenceBailey, D. G., Dresser, G. K. and Bend, J. R. ( 2003 ). Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther. 73: 529 – 537.en_US
dc.identifier.citedreferenceGoosen, T. C., Van Rooyen, J., Erasmus, E. and Potgieter, H. C. ( 2002 ). Cyclosporine pharmacokinetics following co‐administration with grapefruit juice, bergamottin or vitamin E TPGS in rats [abstract]. Pharmacologist. 44: A172.en_US
dc.identifier.citedreferenceMohri, K. and Uesawa, Y. ( 2001 ). Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm Res. 18: 177 – 182.en_US
dc.identifier.citedreferenceAhnoff, M. ( 1984 ). Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Anal. 2: 519 – 526.en_US
dc.identifier.citedreferenceBailey, D. G., Dresser, G. K., Kreeft, J. H., Munoz, C., Freeman, D. J. and Bend, J. R. ( 2000 ). Grapefruit‐felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther. 68: 468 – 477.en_US
dc.identifier.citedreferencePaine, M. F., Widmer, W., Hart, H. L., Brown, S. S., Thomas, B. F. and Pusek, S. N., et al. ( 2003 ). A furanocoumarin‐free grapefruit juice does not alter the oral pharmacokinetics of felodipine [abstract]. Drug Metab Rev. 35 ( Suppl 2 ): 67.en_US
dc.identifier.citedreferenceOhta, T., Maruyama, T., Nagahashi, M., Miyamoto, Y., Hosoi, S. and Kiuchi, F., et al. ( 2002 ). Paradisin C: a new CYP3A4 inhibitor from grapefruit juice. Tetrahedron. 58: 6631 – 6635.en_US
dc.identifier.citedreferenceHo, P. C., Saville, D. J. and Wanwimolruk, S. ( 2001 ). Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci. 4: 217 – 227.en_US
dc.identifier.citedreferenceCriss, A. B., Paine, M. F. and Watkins, P. B. ( 2002 ). The two major furocoumarins in grapefruit juice have distinct absorption and protein binding characteristics [abstract]. Drug Metab Rev. 34 ( Suppl 1 ): 169.en_US
dc.identifier.citedreferenceCummins, C. L., Jacobsen, W. and Benet, L. Z. ( 2002 ). Unmasking the dynamic interplay between intestinal P‐glycoprotein and CYP3A4. J Pharmacol Exp Ther. 300: 1036 – 1045.en_US
dc.identifier.citedreferenceKoenigs, L. L. and Trager, W. F. ( 1998 ). Mechanism‐based inactivation of cytochrome P450 2B1 by 8‐methoxypsoralen and several other furanocoumarins. Biochemistry. 37: 13184 – 13193.en_US
dc.identifier.citedreferenceWrighton, S. A., Schuetz, E. G., Thummel, K. E., Shen, D. D., Korzekwa, K. R. and Watkins, P. B. ( 2000 ). The human CYP3A subfamily: practical considerations. Drug Metab Rev. 32: 339 – 361.en_US
dc.identifier.citedreferenceMayhew, B. S., Jones, D. R. and Hall, S. D. ( 2000 ). An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. Drug Metab Dispos. 28: 1031 – 1037.en_US
dc.identifier.citedreferenceBailey, D. G., Spence, J. D., Munoz, C. and Arnold, J. M. ( 1991 ). Interaction of citrus juices with felodipine and nifedipine. Lancet. 337: 268 – 269.en_US
dc.identifier.citedreferenceEdgar, B., Regardh, C. G., Johnsson, G., Johansson, L., Lundborg, P. and Lofberg, I., et al. ( 1985 ). Felodipine kinetics in healthy men. Clin Pharmacol Ther. 38: 205 – 211.en_US
dc.identifier.citedreferenceBailey, D. G., Arnold, J. M. and Spence, J. D. ( 1998 ). Grapefruit juice‐drug interactions. Br J Clin Pharmacol. 46: 101 – 110.en_US
dc.identifier.citedreferenceBailey, D. G., Bend, J. R., Arnold, J. M., Tran, L. T. and Spence, J. D. ( 1996 ). Erythromycin‐felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin Pharmacol Ther. 60: 25 – 33.en_US
dc.identifier.citedreferenceDucharme, M. P., Warbasse, L. H. and Edwards, D. J. ( 1995 ). Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther. 57: 485 – 491.en_US
dc.identifier.citedreferenceKupferschmidt, H. H., Ha, H. R., Ziegler, W. H., Meier, P. J. and Krahenbuhl, S. ( 1995 ). Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther. 58: 20 – 28.en_US
dc.identifier.citedreferenceLundahl, J., Regardh, C. G., Edgar, B. and Johnsson, G. ( 1997 ). Effects of grapefruit juice ingestion—pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol. 52: 139 – 145.en_US
dc.identifier.citedreferenceLown, K. S., Bailey, D. G., Fontana, R. J., Janardan, S. K., Adair, C. H. and Fortlage, L. A., et al. ( 1997 ). Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest. 99: 2545 – 2553.en_US
dc.identifier.citedreferenceCorreia, M. A., Davoll, S. H., Wrighton, S. A. and Thomas, P. E. ( 1992 ). Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5‐dicarbethoxy‐2,6‐dimethyl‐4‐ethyl‐1,4‐dihydropyridine: characterization of the proteolytic system. Arch Biochem Biophys. 297: 228 – 238.en_US
dc.identifier.citedreferenceTakanaga, H., Ohnishi, A., Matsuo, H. and Sawada, Y. ( 1998 ). Inhibition of vinblastine efflux mediated by P‐glycoprotein by grapefruit juice components in Caco‐2 cells. Biol Pharm Bull. 21: 1062 – 1066.en_US
dc.identifier.citedreferenceEagling, V. A., Profit, L. and Back, D. J. ( 1999 ). Inhibition of the CYP3A4‐mediated metabolism and P‐glycoprotein‐mediated transport of the HIV‐1 protease inhibitor saquinavir by grapefruit juice components. Br J Clin Pharmacol. 48: 543 – 552.en_US
dc.identifier.citedreferenceOhnishi, A., Matsuo, H., Yamada, S., Takanaga, H., Morimoto, S. and Shoyama, Y., et al. ( 2000 ). Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco‐2 cells and on the activity of cytochrome P450 3A4. Br J Pharmacol. 130: 1369 – 1377.en_US
dc.identifier.citedreferenceSpahn‐Langguth, H. and Langguth, P. ( 2001 ). Grapefruit juice enhances intestinal absorption of the P‐glycoprotein substrate talinolol. Eur J Pharm Sci. 12: 361 – 367.en_US
dc.identifier.citedreferenceBecquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M. and Jaillon, P., et al. ( 2001 ). Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther. 70: 311 – 316.en_US
dc.identifier.citedreferenceMalhotra, S., Bailey, D. G., Paine, M. F. and Watkins, P. B. ( 2001 ). Seville orange juice‐felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther. 69: 14 – 23.en_US
dc.identifier.citedreferenceDresser, G. K., Bailey, D. G. and Carruthers, S. G. ( 2000 ). Grapefruit juice‐felodipine interaction in the elderly. Clin Pharmacol Ther. 68: 28 – 34.en_US
dc.identifier.citedreferenceBailey, D. G., Arnold, J. M., Strong, H. A., Munoz, C. and Spence, J. D. ( 1993 ). Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther. 54: 589 – 594.en_US
dc.identifier.citedreferenceBailey, D. G., Arnold, J. M., Munoz, C. and Spence, J. D. ( 1993 ). Grapefruit juice‐felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther. 53: 637 – 642.en_US
dc.identifier.citedreferenceRashid, T., McKinstry, C., Renwick, A. G., Dirnhuber, M., Waller, D. G. and George, C. F. ( 1993 ). Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol. 36: 460 – 463.en_US
dc.identifier.citedreferenceFukuda, K., Guo, L., Ohashi, N., Yoshikawa, M. and Yamazoe, Y. ( 2000 ). Amounts and variation in grapefruit juice of the main components causing grapefruit‐drug interaction. J Chromatogr B Biomed Sci Appl. 741: 195 – 203.en_US
dc.identifier.citedreferenceGuo, L. Q., Fukuda, K., Ohta, T. and Yamazoe, Y. ( 2000 ). Role of furanocoumarin derivatives on grapefruit juice‐mediated inhibition of human CYP3A activity. Drug Metab Dispos. 28: 766 – 771.en_US
dc.identifier.citedreferenceHe, K., Iyer, K. R., Hayes, R. N., Sinz, M. W., Woolf, T. F. and Hollenberg, P. F. ( 1998 ). Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol. 11: 252 – 259.en_US
dc.identifier.citedreferenceTassaneeyakul, W., Guo, L. Q., Fukuda, K., Ohta, T. and Yamazoe, Y. ( 2000 ). Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys. 378: 356 – 363.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cptclpt2004537.pdf
Size:
181.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.